| PEOPX | VSTSX | PEOPX / VSTSX | |
| Total Expense Ratio | 0.50 | 0.01 | 5,000% |
| Annual Report Gross Expense Ratio | 0.51 | 0.01 | 5,100% |
| Fund Existence | 37 years | 10 years | - |
| Gain YTD | 11.078 | 11.205 | 99% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 5000000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.74B | 2.3T | 0% |
| Annual Yield % from dividends | 0.68 | 1.07 | 63% |
| Returns for 1 year | 11.34 | 21.48 | 53% |
| Returns for 3 years | 34.30 | 67.06 | 51% |
| Returns for 5 years | 12.77 | 66.56 | 19% |
| Returns for 10 years | 38.88 | 239.53 | 16% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RHTX | 19.89 | N/A | N/A |
| RH Tactical Outlook ETF | |||
| PZT | 22.53 | -0.01 | -0.04% |
| Invesco New York AMT-Free Muni Bd ETF | |||
| DLNV | 33.01 | -0.03 | -0.08% |
| FT Vest U.S. Equity Dl Drctl Buf ETF Nov | |||
| DFIV | 55.32 | -0.11 | -0.20% |
| Dimensional International Value ETF | |||
| HQL | 19.88 | -0.40 | -1.97% |
| abrdn Life Sciences Investors | |||